Sr Director, Analytical Operations

Start free →

Or apply yourself on the official page →

About the role

At Gilead, we’re creating a healthier world for all people. For more than 35 years, we’ve tackled diseases such as HIV, viral hepatitis, COVID-19 and cancer – working relentlessly to develop therapies that help improve lives and to ensure access to these therapies across the globe. We continue to fight against the world’s biggest health challenges, and our mission requires collaboration, determination and a relentless drive to make a difference.   Every member of Gilead’s team plays a critical role in the discovery and development of life-changing scientific innovations. Our employees are our greatest asset as we work to achieve our bold ambitions, and we’re looking for the next wave of passionate and ambitious people ready to make a direct impact.   We believe every employee deserves a great leader. People Leaders are the cornerstone to the employee experience at Gilead and Kite. As a people leader now or in the future, you are the key driver in evolving our culture and creating an environment where every employee feels included, developed and empowered to fulfil their aspirations. Join Gilead and help create possible, together. Job Description   The Senior Director in Pivotal and Commercial Biologics Analytical Development, will be responsible for leading analytical development activities spanning structural characterization of protein-based modalities, establishing robust and comprehensive pivotal and commercial stage comparability strategies, establishing product-specific critical quality attributes (CQAs), and devising analytical testing strategies for characterization and control of glycosylation variants and excipient-related attributes. They will be responsible for a group of approximately 20 scientists by providing guidance, prioritization, and career development leadership. Through these activities they will play an instrumental role in ensuring the establishment of robust control strategies to support regulatory filing strategies.   Responsibilities:  • Provide leadership to a group of analytical development scientists • Mentor and guide scientists in their roles • Oversee budgeting for capital equipment • Set clear expectations and prioritization of work packages • Manage workload and resources effectively • Accountable for: • Leading extended characterization studies, including those that employ mass spectrometry and other biophysical techniques • Define and implement phase-appropriate analytical comparability strategies for pivotal and post-approval manufacturing changes, including risk assessment, study design, assessment criteria, data interpretation, and regulatory justification • Building patient-centric considerations into overall control strategies – particularly as it pertains to identifying and assessing CQAs based on clinical relevance and product risk. • Establish and maintain a state-of-the-art analytical laboratory ·       Guide the authoring, review and approval of CMC sections in regulatory filings, and support interactions with health agencies ·       Collaborate across Gilead Pharmaceutical Development & Manufacturing (PDM) and partner with Quality, Supply Chain, Manufacturing, CMC Regulatory Affairs, Clinical Development and Technical Development to ensure timely delivery and successful commercialization of the late-stage Biologics portfolio ·       Exhibit comprehensive knowledge of cGMP practices and requirements ·       Act as a key member of the Analytical Development leadership team to shape late-stage development strategies ·       Demonstrate comprehensive knowledge in key analytical CMC strategic areas including CQAs, separations methods, method bridging, reference standards, comparability, and specifications ·       Drive adoption of novel and state-of-the-art analytical technologi

View the official posting →